Abstract
A large number of human diseases are caused by fungus and the plant kingdom has proven to be a source of antifungal compounds. This work describes the in vitro activity of the natural product (R)-goniothalamin and its synthetic enantiomer, (S)-goniothalamin, against eleven strains of human pathogenic fungi. The minimum inhibitory concentration (MIC) values for both enantiomers were lower than 100 μg/mL for nine of the fungus strains studied. MIC values for both enantiomers against isolates of the dimorphic fungus Paracoccidioides braziliensis were in the range of 7-22 μg/mL. (R)- and (S)- goniothalamin were selective for the fungi strains presenting minimal toxic effects on mammalian kidney (Vero) and lung (V79) cell lines.
Keywords: Fungi infections, Goniothalamus, Goniothalamin, Antifungal agents, Minimum inhibitory concentration, Antiproliferative activity
Letters in Drug Design & Discovery
Title: Antifungal Activity of Goniothalamin Enantiomers
Volume: 5 Issue: 1
Author(s): Angelo de Fatima, Cleide Viviane Buzanello Martins, Maria Aparecida de Resende, Thais Furtado Ferreira Magalhaes, Bruno Henrique Santiago Lima, Gisele Almeida Watanabe, Ana Lucia Tasca Gois Ruiz, Joao Ernesto de Carvalho and Ronaldo Aloise Pilli
Affiliation:
Keywords: Fungi infections, Goniothalamus, Goniothalamin, Antifungal agents, Minimum inhibitory concentration, Antiproliferative activity
Abstract: A large number of human diseases are caused by fungus and the plant kingdom has proven to be a source of antifungal compounds. This work describes the in vitro activity of the natural product (R)-goniothalamin and its synthetic enantiomer, (S)-goniothalamin, against eleven strains of human pathogenic fungi. The minimum inhibitory concentration (MIC) values for both enantiomers were lower than 100 μg/mL for nine of the fungus strains studied. MIC values for both enantiomers against isolates of the dimorphic fungus Paracoccidioides braziliensis were in the range of 7-22 μg/mL. (R)- and (S)- goniothalamin were selective for the fungi strains presenting minimal toxic effects on mammalian kidney (Vero) and lung (V79) cell lines.
Export Options
About this article
Cite this article as:
Fatima de Angelo, Martins Buzanello Cleide Viviane, de Resende Aparecida Maria, Ferreira Magalhaes Furtado Thais, Santiago Lima Henrique Bruno, Watanabe Almeida Gisele, Gois Ruiz Lucia Tasca Ana, de Carvalho Ernesto Joao and Pilli Aloise Ronaldo, Antifungal Activity of Goniothalamin Enantiomers, Letters in Drug Design & Discovery 2008; 5 (1) . https://dx.doi.org/10.2174/157018008783406732
DOI https://dx.doi.org/10.2174/157018008783406732 |
Print ISSN 1570-1808 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-628X |
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Knemometry for Assessment of Growth Suppressive Effects of Exogenous Glucocorticoids
Current Pediatric Reviews Atrial Tachycardias Arising from the Atrial Appendages and Aortic Sinus of Valsalva
Current Cardiology Reviews Natural Products Towards the Discovery of Potential Future Antithrombotic Drugs
Current Pharmaceutical Design Medications Affecting Functional Status in Older Persons
Current Pharmaceutical Design Tuberculosis Deaths Among Populations with High HIV Prevalence
Current Respiratory Medicine Reviews Sirtuins: Possible Clinical Implications in Cardio and Cerebrovascular Diseases
Current Drug Targets Overview of Angiogenesis and the use of Bevacizumab in Patients with Malignant Gliomas
Current Signal Transduction Therapy Nocturia in Obstructive Sleep Apnea-Hypopnea Syndrome: An Underappreciated Symptom
Current Respiratory Medicine Reviews Update on Cancer Related Issues of Mesenchymal Stem Cell-Based Therapies
Current Stem Cell Research & Therapy Nociceptin/Orphanin FQ Peptide Receptors: Pharmacology and Clinical Implications
Current Drug Targets Prostacyclin, Atherothrombosis and Diabetes Mellitus: Physiologic and Clinical Considerations
Current Molecular Medicine Model Systems for Pulmonary Infectious Diseases: Paradigms of Anthrax and Tuberculosis
Current Topics in Medicinal Chemistry Therapeutic Gene Products Delivery by Neuron Stem Cells
Current Pharmaceutical Biotechnology Pentraxins and Atherosclerosis: The Role of PTX3
Current Pharmaceutical Design Angiotensin (1-7) and other Angiotensin Peptides
Current Pharmaceutical Design Stem Cell Therapy for Spinal Cord Injury
Current Medicinal Chemistry Immunologic Considerations in Heart Transplantation for Congenital Heart Disease
Current Cardiology Reviews Molecular Chaperone ORP150 in ER Stress–related Diseases
Current Pharmaceutical Design Indolinones as Promising Scaffold as Kinase Inhibitors: A Review
Mini-Reviews in Medicinal Chemistry Combining Bevacizumab with Radiation or Chemoradiation for Solid Tumors: A Review of the Scientific Rationale, and Clinical Trials
Current Angiogenesis (Discontinued)